fMRI-Based Depression Biotype Classification System
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current depression diagnosis methods rely on subjective clinical symptom approaches, which are inadequate for accurately diagnosing depression subtypes and predicting treatment responses, leading to challenges in understanding pathophysiology and developing effective treatments.
Innovation Solution
A method and system that classify neurophysiological depression biotypes in the brain using fMRI data by extracting brain region functional connectivity information and applying classifiers to identify depression biotypes and predict treatment responses, incorporating techniques like principal component analysis and linear support vector machine classifiers.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional subjective clinical symptom approaches are used for depression diagnosis, then the diagnostic process is simple and accessible, but the accuracy and objectivity of diagnosing depression subtypes deteriorates
Solution Approach 1:
The patent replaces the mechanical/manual clinical symptom assessment system with an automated neuroimaging-based diagnostic system. fMRI technology captures objective brain activity data, which is then processed through computational algorithms to identify depression biotypes, substituting subjective clinical judgment with objective physiological measurements and automated analysis.
Solution Approach 2:
The patent introduces brain functional connectivity patterns as an intermediary between the patient's neurological state and the depression diagnosis. Instead of directly assessing symptoms, the system measures brain region interactions via fMRI, using these patterns as intermediate indicators to objectively classify depression subtypes and predict treatment responses.
2Reliability
If neuroimaging-based biotype classification is implemented, then objectivity and precision of depression diagnosis is improved, but the complexity and cost of the diagnostic system increases
Solution Approach 1:
The patent segments the complex brain into specific functional regions and analyzes connectivity patterns between predefined brain areas. By dividing the diagnostic task into region-specific functional connectivity assessments rather than whole-brain analysis, the system maintains reliability while reducing computational complexity and making the diagnostic process more manageable.
3Measurement precision
If multiple brain regions and functional connectivity patterns are analyzed, then the precision of depression biotype identification is improved, but the data processing complexity and time required increases
Solution Approach 1:
The patent applies preliminary action by pre-defining regions of interest and connectivity patterns based on prior neuroscience research and validation studies. These predetermined analytical frameworks are established before patient assessment, allowing the system to quickly evaluate brain data against known biotype patterns without requiring de novo analysis of all possible brain connections, thus reducing processing time while maintaining precision.
Data Source
AI summary
The methods and systems described herein enable the accurate diagnosis of novel biotypes of depression that transcend current diagnostic boundaries and may be useful for identifying individuals who are most likely to benefit from antidepressant treatment. Functional magnetic resonance imaging is used to characterize the architecture of functional connectivity across the brain to show that patients with depression can be subdivided into four neurophysiological biotypes based solely on unique patterns of abnormal connectivity in resting state brain networks. Clustering subjects on this basis reduces diagnostic heterogeneity, enabling the development of depression biotype classifiers for diagnosing biotypes of depresion in individual patients, These biotypes also predict differing responses to antidepressant treatment, and abnormal connectivity patterns can be used to track changes in depression severity over time.